Description

GEMZAR® is a nucleoside metabolic inhibitor indicated:
• in combination with carboplatin, for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy. (1.1)
• in combination with paclitaxel, for first-line treatment of metastatic breast cancer after failure of prior anthracycline-containing adjuvant chemotherapy, unless anthracyclines were clinically contraindicated. (1.2)
• in combination with cisplatin, for the treatment of non-small cell lung cancer. (1.3)
• as a single agent for the treatment of pancreatic cancer. (1.4)